Eurobio Scientific Société anonyme (EPA: ALERS)

Market Cap	254.10M
Revenue (ttm)	144.73M
Net Income (ttm)	6.64M
Shares Out	10.04M
EPS (ttm)	0.60
PE Ratio	42.13
Forward PE	28.75
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,130
Open	25.20
Previous Close	25.30
Day's Range	23.50 - 25.20
52-Week Range	13.80 - 26.00
Beta	-0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 24, 2024

About EPA: ALERS

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and cancer. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, a molecular test for the surveillance of heart-transplant patients; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the ev...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 300
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALERS

Financial Performance

In 2023, ALERS's revenue was 130.65 million, a decrease of -14.55% compared to the previous year's 152.90 million. Earnings were 4.84 million, a decrease of -80.61%.